title: Null genotype of GSTT1 contributes to increased Parkinson's disease risk in Caucasians: evidence from a meta-analysis.
abstract: Conflicting results in previous case-control studies on the association between Glutathione S-transferase T1 (GSTT1) gene polymorphism and Parkinson's disease (PD) risk have been reported, so we conducted this meta-analysis. We searched and extracted data from 3 Chinese and 3 English web-based electronic databases to evaluate the associations by odds ratio (OR) and its 95% confidence interval (CI) under the recessive genetic comparison model (null genotype vs. present genotype). We also conducted subgroup analyses by ethnicity and adjusted status of OR, respectively. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also reanalyzed. When 18 eligible studies (3,963 PD cases and 5,472 controls) were pooled to analyze the association, we found no statistically significant result (OR 1.24, 95% CI 0.96-1.60). In the subgroup analyses by ethnicity, there was statistically significant association between the null genotype of GSTT1 and PD risk among Caucasians, while the associations were not found among Asians and Latinos. In the subgroup analyses by adjusted status of OR, there were no significant associations both in studies with crude OR and adjusted OR. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also confirmed the associations mentioned above. Power analysis indicated only meta-analysis of Caucasians had enough evidence to claim the association. In conclusion, the meta-analysis suggests that the null genotype of GSTT1 contributes to PD risk in Caucasians, and no association in Asians is needed more studies to confirm.
authors.affiliation: Department of Epidemiology and Biostatistics, School of Public Health, Hebei Medical University, No. 361 Zhongshan East Road, Shijiazhuang, 050017, Hebei, China.
authors.forename: Dan
authors.initials: D
authors.lastname: Wang
authors.forename: Jun-Xia
authors.initials: JX
authors.lastname: Zhai
authors.forename: Li-Mei
authors.initials: LM
authors.lastname: Zhang
authors.forename: Dian-Wu
authors.initials: DW
authors.lastname: Liu
mesh_terms: D005808:Genes, Recessive / Q000235:genetics; D056726:Genetic Association Studies; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D008957:Models, Genetic; D016017:Odds Ratio; D010300:Parkinson Disease / Q000235:genetics*; D044465:White People / Q000235:genetics*
chemical_list: C413545:glutathione S-transferase T1; D005982:Glutathione Transferase
references.citation: Mol Cell Biochem. 2008 May;312(1-2):131-8
references.pmid: 18327668
references.citation: Lancet. 1998 Oct 24;352(9137):1344-6
references.pmid: 9802272
references.citation: Stat Med. 1988 Aug;7(8):889-94
references.pmid: 3413368
references.citation: J Hepatol. 2010 Sep;53(3):508-18
references.pmid: 20561699
references.citation: Biochem Biophys Res Commun. 2000 Mar 24;269(3):676-80
references.pmid: 10720475
references.citation: Mov Disord. 2012 Nov;27(13):1652-8
references.pmid: 23045187
references.citation: Lancet. 1997 Oct 18;350(9085):1136-9
references.pmid: 9343502
references.citation: Hum Exp Toxicol. 1999 Mar;18(3):141-5
references.pmid: 10215103
references.citation: Arq Neuropsiquiatr. 2013 Aug;71(8):527-32
references.pmid: 23982010
references.citation: Parkinsonism Relat Disord. 2012 Jun;18(5):664-5
references.pmid: 21993019
references.citation: Cell. 2010 Mar 19;140(6):918-34
references.pmid: 20303880
references.citation: Neurosci Lett. 2004 Aug 19;366(3):326-31
references.pmid: 15288444
references.citation: Rheumatology (Oxford). 2010 Apr;49(4):652-6
references.pmid: 20047981
references.citation: Neurosci Lett. 2007 Feb 21;413(3):274-8
references.pmid: 17194543
references.citation: Neurosci Lett. 2003 Jan 30;337(1):5-8
references.pmid: 12524158
references.citation: J Neural Transm (Vienna). 2000;107(3):331-4
references.pmid: 10821441
references.citation: Am J Epidemiol. 2003 Jun 1;157(11):1015-22
references.pmid: 12777365
references.citation: Parkinsonism Relat Disord. 2010 Aug;16(7):447-52
references.pmid: 20472488
references.citation: Occup Environ Med. 2007 Oct;64(10):673-80
references.pmid: 17449559
references.citation: Pharmacology. 2000 Sep;61(3):154-66
references.pmid: 10971201
references.citation: Cell Mol Neurobiol. 2013 Jul;33(5):673-80
references.pmid: 23552977
references.citation: Br J Ophthalmol. 2009 Aug;93(8):1101-4
references.pmid: 19286687
references.citation: Lancet. 1998 Dec 19-26;352(9145):1986-7
references.pmid: 9872254
references.citation: J Gastroenterol Hepatol. 2012 Feb;27(2):231-7
references.pmid: 21916987
references.citation: Int J Mol Sci. 2013 Jan 24;14(2):2388-409
references.pmid: 23348931
references.citation: Annu Rev Neurosci. 2005;28:57-87
references.pmid: 16022590
references.citation: BMJ. 2007 Nov 3;335(7626):914-6
references.pmid: 17974687
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):38-47
references.pmid: 22095653
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120